| Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans J Seow, C Graham, B Merrick, S Acors, S Pickering, KJA Steel, ... Nature microbiology 5 (12), 1598-1607, 2020 | 1534 | 2020 |
| Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis JL Nieto-Torres, ML DeDiego, C Verdiá-Báguena, JM Jimenez-Guardeño, ... PLoS pathogens 10 (5), e1004077, 2014 | 625 | 2014 |
| Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome JL Nieto-Torres, C Verdiá-Báguena, JM Jimenez-Guardeño, ... Virology 485, 330-339, 2015 | 550 | 2015 |
| Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival ML DeDiego, JL Nieto-Torres, JA Regla-Nava, JM Jimenez-Guardeño, ... Journal of virology 88 (2), 913-924, 2014 | 438 | 2014 |
| Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia L Braga, H Ali, I Secco, E Chiavacci, G Neves, D Goldhill, R Penn, ... Nature 594 (7861), 88-93, 2021 | 338 | 2021 |
| Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein JL Nieto-Torres, ML DeDiego, E Álvarez, JM Jiménez-Guardeño, ... Virology 415 (2), 69-82, 2011 | 292 | 2011 |
| The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis JM Jimenez-Guardeño, JL Nieto-Torres, ML DeDiego, JA Regla-Nava, ... PLoS pathogens 10 (8), e1004320, 2014 | 263 | 2014 |
| Role of severe acute respiratory syndrome coronavirus viroporins E, 3a, and 8a in replication and pathogenesis C Castaño-Rodriguez, JM Honrubia, J Gutiérrez-Álvarez, ML DeDiego, ... MBio 9 (3), 10.1128/mbio. 02325-17, 2018 | 254 | 2018 |
| Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis ML DeDiego, JL Nieto-Torres, JM Jiménez-Guardeño, JA Regla-Nava, ... PLoS pathogens 7 (10), e1002315, 2011 | 229 | 2011 |
| Coronavirus virulence genes with main focus on SARS-CoV envelope gene ML DeDiego, JL Nieto-Torres, JM Jimenez-Guardeño, JA Regla-Nava, ... Virus research 194, 124-137, 2014 | 196 | 2014 |
| Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates JA Regla-Nava, JL Nieto-Torres, JM Jimenez-Guardeño, ... Journal of virology 89 (7), 3870-3887, 2015 | 164 | 2015 |
| Identification of the mechanisms causing reversion to virulence in an attenuated SARS-CoV for the design of a genetically stable vaccine JM Jimenez-Guardeño, JA Regla-Nava, JL Nieto-Torres, ML DeDiego, ... PLoS pathogens 11 (10), e1005215, 2015 | 160 | 2015 |
| Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B. 1.1. 7 variant C Graham, J Seow, I Huettner, H Khan, N Kouphou, S Acors, H Winstone, ... Immunity 54 (6), 1276-1289. e6, 2021 | 118 | 2021 |
| Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern L Dupont, LB Snell, C Graham, J Seow, B Merrick, T Lechmere, ... Nature microbiology 6 (11), 1433-1442, 2021 | 98 | 2021 |
| Immunoproteasome activation enables human TRIM5α restriction of HIV-1 JM Jimenez-Guardeño, L Apolonia, G Betancor, MH Malim Nature Microbiology 4 (6), 933-940, 2019 | 71 | 2019 |
| The envelope protein of severe acute respiratory syndrome coronavirus interacts with the non-structural protein 3 and is ubiquitinated E Alvarez, ML DeDiego, JL Nieto-Torres, JM Jiménez-Guardeño, ... Virology 402 (2), 281-291, 2010 | 58 | 2010 |
| Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction MDJ Dicks, G Betancor, JM Jimenez-Guardeño, L Pessel-Vivares, ... PLoS pathogens 14 (11), e1007408, 2018 | 53 | 2018 |
| An overview of vaccines against SARS-CoV-2 in the COVID-19 pandemic era A Pascual-Iglesias, J Canton, AM Ortega-Prieto, JM Jimenez-Guardeño, ... Pathogens 10 (8), 1030, 2021 | 46 | 2021 |
| Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation MJ Lista, PM Matos, TJA Maguire, K Poulton, E Ortiz-Zapater, R Page, ... PLoS One 16 (9), e0256813, 2021 | 37 | 2021 |
| Impact of the B. 1.1. 7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike C Graham, J Seow, I Huettner, H Khan, N Kouphou, S Acors, H Winstone, ... bioRxiv, 2021 | 31 | 2021 |
